Marker Therapeutics, Inc. (MRKR)

CIK 1094038 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Marker Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001104659-26-097262
May 15, 202610-Q0001104659-26-062763
May 4, 20268-K0001104659-26-054940
Mar 20, 2026DEFA14A0001104659-26-032708
Mar 20, 2026ARS0001104659-26-032704
Mar 20, 2026DEF 14A0001104659-26-032694
Mar 19, 20268-K0001104659-26-031309
Mar 18, 202610-K0001104659-26-031274
Mar 10, 2026PRE 14A0001104659-26-025917
Feb 9, 20268-K0001104659-26-012063
Nov 19, 202540001768011-25-000003
Nov 19, 202540001270905-25-000003
Nov 19, 202540001104659-25-114081
Nov 17, 2025SCHEDULE 13D/A0001072613-25-000858
Nov 14, 2025SCHEDULE 13G/A0001172661-25-005191
Nov 14, 20258-K0001104659-25-111940
Nov 13, 202510-Q0001104659-25-111502
Nov 5, 20258-K0001104659-25-106669
Nov 4, 202540001884123-25-000010
Nov 4, 202530001884123-25-000009
Nov 4, 202540001755495-25-000003
Oct 6, 20258-K0001104659-25-096935
Aug 26, 20258-K0001104659-25-082783
Aug 20, 2025SCHEDULE 13D/A0001104659-25-080957
Aug 19, 2025SCHEDULE 13D/A0001104659-25-080213